Sio Capital Management, LLC
Filing Date
Global Rank
#2,191
/ 8,586
▲ 109
Top Industry
Biotechnology
45.4%
3Y Alpha vs SPY
-1.3%
Period ended 3 months ago
Filed May 14, 2026 · 33d
25 quarters · since Mar 2020
Clone Performance
Jun 2023–Jun 2026 · vs SPYHypothetical growth of cloning every reported 13F position and rebalancing on each filing, indexed to the same start.
Cloned portfolio
+72.5%
SPY
+78.1%
Annualised alpha
-1.3%
Max drawdown
−37.3%
Estimate. 13F holdings are quarter-lagged and long-only, so the clone rebalances about 45 days after each period end — when the filing becomes public — and excludes options and short positions. Past performance does not predict future results.
Portfolio Concentration
72 positions · as of Mar 31, 2026 · Δ vs Dec 31, 2025Top Position
7.1%
−0.1 pts
Top 5
26.7%
−6.7 pts
Top 10
45.2%
−6.6 pts
HHI
302
Diversified−69
Portfolio Trend
25 quarters · across all stocks
Sector Breakdown
As of Mar 31, 2026| Sector | % Portfolio | Value |
|---|---|---|
| Healthcare | 92.5% | $643,534,248 |
| Industrials | 7.1% | $49,281,682 |
| Unclassified | 0.4% | $3,060,613 |
Last Quarter's Activity
Export CSVAdded To
Positions the filer increased
24 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| AVR | Anteris Technologies Global Corp. | +3,508,324 | 5,382,965 | $29,875,455 | |
| WAY | Waystar Holding Corp. | +1,028,511 | 1,642,236 | $39,594,309 | |
| VIR | Vir Biotechnology, Inc. | +1,020,277 | 1,498,620 | $13,427,635 | |
| AQST | Aquestive Therapeutics, Inc. | +929,792 | 1,922,887 | $7,979,981 | |
| PMVP | PMV Pharmaceuticals, Inc. | +440,032 | 3,076,580 | $3,814,959 | |
| MMS | Maximus, Inc. | +268,521 | 768,825 | $49,281,682 | |
| TARA | Protara Therapeutics, Inc. | +254,445 | 1,969,839 | $10,262,861 | |
| RAPP | Rapport Therapeutics, Inc. | +181,544 | 366,809 | $11,477,453 | |
| ICLR | Icon PLC | +179,156 | 306,358 | $33,901,576 | |
| ANIP | Ani Pharmaceuticals Inc | +178,271 | 265,543 | $20,420,256 | |
| IBIO | iBio, Inc. | +164,268 | 904,268 | $1,718,109 | |
| HAE | Haemonetics Corp | +128,041 | 220,672 | $12,437,073 | |
| CRNX | Crinetics Pharmaceuticals, Inc. | +125,046 | 249,887 | $9,075,895 | |
| LIVN | LivaNova PLC | +99,233 | 421,615 | $26,797,849 | |
| ABVX | Abivax S.A. | +92,676 | 135,800 | $15,121,330 | |
| COR | Cencora, Inc. | +84,994 | 100,894 | $31,694,841 | |
| TYRA | Tyra Biosciences, Inc. | +79,437 | 605,439 | $23,188,313 | |
| EWTX | Edgewise Therapeutics, Inc. | +31,505 | 268,986 | $8,473,059 | |
| CCRN | Cross Country Healthcare Inc | +29,572 | 1,098,393 | $10,324,894 | |
| ORKA | Oruka Therapeutics, Inc. | +14,370 | 132,496 | $6,498,928 | |
| TFX | Teleflex Inc | +7,924 | 94,800 | $11,339,028 | |
| IRON | Disc Medicine, Inc. | +7,617 | 65,203 | $4,169,079 | |
| GPCR | Structure Therapeutics Inc. | +7,593 | 209,093 | $10,078,282 | |
| DRUG | Bright Minds Biosciences Inc. | +4,200 | 86,083 | $6,281,476 | |
| No positions match the current search. | |||||
Trimmed
Positions the filer reduced
16 positions
| Ticker | Company | Δ Shares | Shares | Value | Open |
|---|---|---|---|---|---|
| OGN | Organon & Co. | −2,555,857 | 865,908 | $5,186,788 | |
| HYPR | Hyperfine, Inc. | −1,000,000 | 1,000,000 | $1,080,000 | |
| SNY | Sanofi | −732,015 | 239,671 | $11,547,348 | |
| NMTC | NEUROONE MEDICAL TECHNOLOGIES Corp | −643,426 | 496,614 | $385,869 | |
| CNTX | Context Therapeutics Inc. | −423,714 | 917,922 | $2,404,955 | |
| ZBH | Zimmer Biomet Holdings, Inc. | −323,029 | 62,613 | $5,661,467 | |
| ELTX | Elicio Therapeutics, Inc. | −285,200 | 11,700 | $125,073 | |
| CELC | Celcuity Inc. | −283,224 | 193,843 | $22,125,240 | |
| PRQR | ProQR Therapeutics N.V. | −209,466 | 1,954,715 | $3,166,638 | |
| OVID | Ovid Therapeutics Inc. | −175,114 | 1,252,381 | $2,780,285 | |
| CNC | Centene Corp | −174,350 | 100,000 | $3,274,000 | |
| DNTH | Dianthus Therapeutics, Inc. /DE/ | −104,458 | 370,045 | $31,054,176 | |
| BHVN | Biohaven Ltd. | −80,838 | 1,163,926 | $9,846,813 | |
| BMRN | Biomarin Pharmaceutical Inc | −38,462 | 194,226 | $10,971,826 | |
| SI | Shoulder Innovations, Inc. | −17,330 | 210,641 | $3,060,613 | |
| ALGS | Aligos Therapeutics, Inc. | −8,700 | 327,237 | $2,431,370 | |
| No positions match the current search. | |||||
New Positions
Positions the filer opened this quarter
21 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CORT | Corcept Therapeutics Inc | 674,759 | $27,199,535 | |
| GSK | GSK plc | 385,879 | $21,296,662 | |
| ABT | Abbott Laboratories | 186,574 | $19,155,552 | |
| EMBC | Embecta Corp. | 1,847,850 | $16,334,994 | |
| SION | Sionna Therapeutics, Inc. | 294,340 | $11,800,090 | |
| MNPR | Monopar Therapeutics | 173,506 | $9,506,393 | |
| EYPT | EyePoint, Inc. | 721,785 | $9,303,808 | |
| CMPS | COMPASS Pathways plc | 1,506,525 | $8,331,083 | |
| OCUL | Ocular Therapeutix, Inc | 968,597 | $8,204,016 | |
| RLMD | Relmada Therapeutics, Inc. | 965,000 | $6,716,400 | |
| ZBIO | Zenas BioPharma, Inc. | 331,730 | $6,485,321 | |
| QDEL | QuidelOrtho Corp | 359,011 | $5,898,550 | |
| REPL | Replimune Group, Inc. | 720,036 | $5,508,275 | |
| OKUR | OnKure Therapeutics, Inc. | 1,078,965 | $4,466,915 | |
| IMNM | Immunome Inc. | 165,110 | $3,610,955 | |
| IART | Integra Lifesciences Holdings Corp | 383,140 | $3,609,178 | |
| ANTX | AN2 Therapeutics, Inc. | 657,200 | $2,247,624 | |
| SER | Serina Therapeutics, Inc. | 1,000,000 | $1,940,000 | |
| ERAS | Erasca, Inc. | 5,000 | $80,900 | |
| OSCR | Oscar Health, Inc. | 3,000 | $34,410 | |
| SLP | Simulations Plus, Inc. | 200 | $2,364 | |
| No positions match the current search. | ||||
Sold Out
Positions the filer fully exited
14 positions
| Ticker | Company | Shares | Value | Open |
|---|---|---|---|---|
| CI | Cigna Group | 172,203 | $47,395,431 | |
| RYTM | Rhythm Pharmaceuticals, Inc. | 265,700 | $28,440,528 | |
| KVUE | Kenvue Inc. | 1,465,442 | $25,278,874 | |
| XLO | Xilio Therapeutics, Inc. | 2,134,537 | $19,125,451 | |
| BTSG | BrightSpring Health Services, Inc. | 308,010 | $11,534,974 | |
| CRL | Charles River Laboratories International, Inc. | 54,985 | $10,968,407 | |
| MODD | Modular Medical, Inc. | 785,824 | $8,581,198 | |
| MCK | Mckesson Corp | 6,400 | $5,249,856 | |
| FULC | Fulcrum Therapeutics, Inc. | 382,000 | $4,320,420 | |
| ALKS | Alkermes plc. | 95,353 | $2,667,976 | |
| IDYA | IDEAYA Biosciences, Inc. | 75,730 | $2,617,986 | |
| OTLK | Outlook Therapeutics, Inc. | 1,125,400 | $1,778,132 | |
| AVTX | Avalo Therapeutics, Inc. | 72,173 | $1,310,661 | |
| NXTC | NextCure, Inc. | 10,940 | $155,238 | |
| No positions match the current search. | ||||
0 positions ·
$0 total
· Consumer Defensive only
· as of Mar 31, 2026
No positions to show.